Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
BMC Ophthalmology|February 2, 2024
Implementing and evaluating a fully functional AI-enabled model for chronic eye disease screening in a real clinical environmentChristos Skevas, Nicolás Pérez de Olaguer, Albert Lleó, et al.Molecular Neurobiology|September 16, 2016
Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and LimitationsMarta Cosín-Tomás, Anna Antonell, Albert Lladó, et al.Neurobiology of Aging|July 15, 2011
Genetic variation in APOE cluster region and Alzheimer's disease riskSebastián Cervantes, Lluís Samaranch, José Manuel Vidal-Taboada, et al.Neurology and Therapy|June 1, 2022
Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in SpainAlberto Villarejo-Galende, Elena García-Arcelay, Gerard Piñol-Ripoll, et al.Enfermedades Infecciosas Y Microbiologia Clinica|May 7, 2013
[Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders], Daniel Podzamczer Palter, José A Muñoz-Moreno, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
First-in-Class SAM-Competitive G9a Inhibitor FLAV-27 as a Disease-Modifying Therapy for Alzheimer's DiseaseAina Bellver-Sanchis, David Valle-Garcia, Carla Barbaraci, et al.Pageof 1